CA2254528C - Traitement de conditions reliees a l'ischemie telles que la perfusion a repetition et le dysfonctionnement cellulaire, y compris l'arythmie et la defaillance cardiaque suite a un infarctus du myocarde - Google Patents

Traitement de conditions reliees a l'ischemie telles que la perfusion a repetition et le dysfonctionnement cellulaire, y compris l'arythmie et la defaillance cardiaque suite a un infarctus du myocarde Download PDF

Info

Publication number
CA2254528C
CA2254528C CA 2254528 CA2254528A CA2254528C CA 2254528 C CA2254528 C CA 2254528C CA 2254528 CA2254528 CA 2254528 CA 2254528 A CA2254528 A CA 2254528A CA 2254528 C CA2254528 C CA 2254528C
Authority
CA
Canada
Prior art keywords
compound
plp
pyridoxal
treatment
ischemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2254528
Other languages
English (en)
Other versions
CA2254528A1 (fr
Inventor
Naranjan S. Dhalla
Rajat Sethi
Krishnamurti Dakshinamurti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Medicure Inc
Original Assignee
University of Manitoba
Medicure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba , Medicure Inc filed Critical University of Manitoba
Publication of CA2254528A1 publication Critical patent/CA2254528A1/fr
Application granted granted Critical
Publication of CA2254528C publication Critical patent/CA2254528C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CA 2254528 1998-07-09 1998-11-26 Traitement de conditions reliees a l'ischemie telles que la perfusion a repetition et le dysfonctionnement cellulaire, y compris l'arythmie et la defaillance cardiaque suite a un infarctus du myocarde Expired - Fee Related CA2254528C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11227798A 1998-07-09 1998-07-09
US09/112,277 1998-07-09

Publications (2)

Publication Number Publication Date
CA2254528A1 CA2254528A1 (fr) 2000-01-09
CA2254528C true CA2254528C (fr) 2007-07-17

Family

ID=22343046

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2254528 Expired - Fee Related CA2254528C (fr) 1998-07-09 1998-11-26 Traitement de conditions reliees a l'ischemie telles que la perfusion a repetition et le dysfonctionnement cellulaire, y compris l'arythmie et la defaillance cardiaque suite a un infarctus du myocarde

Country Status (4)

Country Link
JP (1) JP2000026295A (fr)
AU (2) AU759824B2 (fr)
CA (1) CA2254528C (fr)
NZ (1) NZ333023A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525303A (ja) * 2000-02-29 2003-08-26 メディキュア インターナショナル インコーポレイテッド 心臓保護ホスホン酸塩およびマロン酸塩
EP1531157B1 (fr) * 2000-02-29 2008-03-19 Medicure International Inc. Phosphonates cardioprotecteurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222664A (en) * 1986-11-29 1990-06-26 Vesta Med Pty Ltd Pharmaceutical compositions containing pyridoxal as a source of vitamin b6
JPH09221425A (ja) * 1996-02-13 1997-08-26 Taiho Yakuhin Kogyo Kk チオールプロテアーゼ阻害剤

Also Published As

Publication number Publication date
JP2000026295A (ja) 2000-01-25
AU9421098A (en) 2000-02-03
AU2007202621A1 (en) 2007-06-28
CA2254528A1 (fr) 2000-01-09
NZ333023A (en) 2000-08-25
AU759824B2 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
CA2368775C (fr) Traitement des pathologies cardiovasculaires et des pathologies connexes
US5760081A (en) Omega 3 fatty acids in the prevention of ventricular fibrillation
US4673563A (en) Adenosine in the treatment of supraventricular tachycardia
Birkhead et al. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.
TWI508726B (zh) 治療心房纖維性顫動之方法
PT1437131E (pt) Utilização de ramipril para a prevenção de diabetes num doente sem insuficiência cardíaca congestiva pré-existente
Dart Jr et al. Carotid sinus nerve stimulation treatment of angina refractory to other surgical procedures
Prystowsky et al. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
JPH07503709A (ja) 虚血及び再潅流による組織障害を改善する方法，及び組成物
WO2007121588A1 (fr) Traitement de la fibrillation auriculaire
US5944020A (en) Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery
Miyazaki et al. Modulation of cardiac autonomic neurotransmission by epicardial superfusion. Effects of hexamethonium and tetrodotoxin.
US5541225A (en) α-Linolenic acid and eicosatetraynoic acid in the prevention and treatment of ventricular tachyarrhythmia
Gunton et al. Changes in cardiac rhythm and in the form of the electrocardiogram resulting from induced hypothermia in man
CA2254528C (fr) Traitement de conditions reliees a l'ischemie telles que la perfusion a repetition et le dysfonctionnement cellulaire, y compris l'arythmie et la defaillance cardiaque suite a un infarctus du myocarde
JPS6129927B2 (fr)
Guerot et al. Electrophysiological study of intravenous pinaverium bromide in cardiology
WO2019131308A1 (fr) TRAITEMENT D'UNE ARYTHMIE EN FAISANT APPEL À LA 9-β-D-ARABINOFURANOSYLHYPOXANTINE
JP2003514863A (ja) Ｎ６置換５’−（ｎ−置換）カルボキサミドアデノシンを用いた心臓調律障害の処置
WO2001015705A1 (fr) Utilisation de fructose-1,6-diphosphate comme medicament inotrope pour le pontage cardiopulmonaire
RU2146933C1 (ru) Способ профилактики и лечения ишемии миокарда при коронароинвазивных вмешательствах
Constantin et al. Autonomie control of ventricular tachycardia. III. Effects of adenosine and N6-R-1-phenyl-2-propyladenosine
HU206612B (en) Process for producing antihypertenzive combinative composition
Hassan et al. THE CARDIOVASCULAR AND PLATELET EFFECTS OF EPOPROSTENOL (PROSTACYLIN, FGF) ARE UNAFFECTED BY/3-ADRENOCEPTOR BLOCKADE IN MAN
Dahlström et al. Electrophysiological effects of prenalterol on the cardiac conduction system

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed